Cancer incidence in Nigeria is growing, and mortality rates are high. This is partly due to the fact that most people struggle to access high-quality medical care; consequently, 80 percent of patients present with late stages of disease that are difficult to treat. Nigeria’s National Institute for Cancer Research and Treatment (NICRAT) is leading efforts to improve cancer prevention, diagnosis, and treatment, with strategic plans to expand cancer registries, screening programs, and the oncology workforce.
NICRAT hosted a roundtable in Abuja, Nigeria, organized by the Milken Institute in collaboration with the Mayo Clinic Comprehensive Cancer Center. This event engaged 50 participants from across the cancer ecosystem to advance solutions for cancer research, prevention, and care in Nigeria. This report summarizes the roundtable themes and insights, key takeaways, and actionable recommendations.
By working together, we can reduce the burden of cancer in Nigeria and improve the lives of those affected.
Related Content
-
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save lives by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships...Read Article -
Metabolic Mind Award Program Update
The Milken Institute in partnership with the Baszucki Brain Research Fund are pleased to announce the individuals selected to receive the 2022 Metabolic Mind Award for their exceptional contributions to the advancement of understanding...Read Article -
The Costs of Chronic Disease in the U.S.
Americans' chronic health problems and diseases not only come at the expense of individuals well-being, they also constitute a massive burden on the U.S. economy. When including the costs of lost economic productivity, the total costs of...Read Report11 11Hugh Waters and Marlon Graf -
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering the market and can identify multiple cancers early and simultaneously. These tests detect signals found in DNA that cancer cells shed into the...Read Report -
Childhood Brain Cancer: A Giving Smarter Guide
Pediatric brain cancer accounts for 16 percent of all new childhood cancer diagnoses, making it one of the most common cancer diagnoses in children and adolescents. It is also the leading cause of cancer death within this age group. Unlike...Read Report -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
August 1, 2023 (SINGAPORE) - The annual Milken Institute Asia Summit, taking place from September 13 – 15, will convene regional and global leaders to discuss a wide range of issues and challenges shaping the Asia Pacific region including...Read ArticleImageYeen Chong
Associate Director, Milken Institute InternationalYeen Chee Chong is an associate director for Milken Institute International. Based in Singapore, he oversees and manages strategic communications with a wide range of global and regional media publications and partners. Chong works closely with colleagues in both Asia and the United States on planning and implementing global public relations and social media campaigns. -
Lessons of the Millennium Development Goals
Did the United Nations' ambitious Millennium Development Goals improve the health of people in emerging regions of the world? In this paper, a discussion of the precursors of higher living standards and better health, Milken Institute...Read Report -
Type 1 Diabetes Autoantibody Screening Implementation Roadmap: 2022 REPORT UPDATE
In April 2021, the Milken Institute, with generous funding from the Leona M. and Harry B. Helmsley Charitable Trust, published a report focused on the implementation of type 1 diabetes (T1D) autoantibody screening in the general population...Read Report -
Toward a National Action Plan for Achieving Diversity in Clinical Trials
This report details the actions organizations and sectors from across the enterprise can take to create a clinical trials enterprise that is diverse, equitable, inclusive, and accessible to all.Read Report11 11 11 11
Esther Krofah, Barbara E. Bierer, MD, Morgan Hanger, Sally Okun, and Willyanne DeCormier Plosky, DrPH -
Improving Early Detection of Cognitive Impairment and Dementia
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...Read Report11 11
Diane Ty, Soo Borson, MD, and Katie Partrick, PhD